National

Attorney General Jeff Sessions announced Tuesday that the Drug Enforcement Administration can now cut back on the amount of opioids a drug manufacturer can produce if the DEA "believes that a company’s opioids are being diverted for misuse." 

Why it matters: This comes after West Virginia sued the DEA in December over the drug quota rules, which were established based on the amount of drugs the manufacturers were expected to sell rather than the amount needed for medical reasons.

Justice Department to crack down on opioid drugmakers

If the DEA "believes that a company’s opioids are being diverted for misuse."

Jeff Sessions with his glasses down on his nose

Health Care

Department of Justice (DOJ)

Attorney General Jeff Sessions announced Tuesday that the Drug Enforcement Administration can now cut back on the amount of opioids a drug manufacturer can produce if the DEA &quot;believes that a company’s opioids are being diverted for misuse.&quot; Why it matters: This comes after West Virginia sued the DEA in December over the drug quota rules, which were established based on the amount of drugs the manufacturers were expected to sell rather than the amount needed for medical reasons.

The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.

Justice Department to crack down on opioid drugmakers

Go deeper